DHL Group and Cryoport (CYRX) are pleased to announce that DHL has acquired 100% of Cryopdp, a specialty courier focused on clinical trials, biopharma, and cell and gene therapies. In this context, the companies also announced a strategic partnership to strengthen their supply chain service offerings for the global life sciences and healthcare sector. The deal and the outlined partnership are subject to regulatory approvals.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYRX:
- CryoPort Sells CRYOPDP to DHL for $138 Million
- Cryoport price target lowered to $10 from $11 at Guggenheim
- Cryoport upgraded to Buy from Neutral at UBS
- CryoPort’s Mixed Performance and Sector Uncertainties Justify Hold Rating
- CryoPort’s Stabilization Amid Market Uncertainties: A Hold Rating Analysis